← Back to Search

Dietary Supplement

Fish Oil + Metformin for Polycystic Ovary Syndrome (PCOS Trial)

Phase 1
Recruiting
Led By Donna F Vine, PhD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female
Age at time of enrollment > 18 to <30 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline and postintervention at 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to see how adding fish oil to the diet of overweight-obese young women with PCOS compares to the standard treatment with metformin in terms of their blood fats and how the body

Who is the study for?
This trial is for overweight or obese young women aged 18-30 with PCOS, who may also have type 2 diabetes. Participants should have high blood triglycerides and signs of insulin resistance. It's not suitable for those without these specific conditions.
What is being tested?
The study aims to compare the effects of fish oil supplements, metformin (a standard diabetes drug), and their combination on blood fats and certain lipoproteins in women with PCOS who are overweight or obese.
What are the potential side effects?
Potential side effects include digestive issues from fish oil like a fishy aftertaste, nausea, bloating, and diarrhea. Metformin can cause stomach upset, diarrhea, muscle pain, low blood sugar levels, and potentially vitamin B12 deficiency.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am female.
Select...
I am between 18 and 30 years old.
Select...
I have been diagnosed with PCOS, showing symptoms like irregular periods and high androgen levels.
Select...
I am a young woman with a BMI over 25, considered overweight or obese.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline and postintervention at 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and postintervention at 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Plasma Triglycerides and apoB-lipoprotein remnants in non-fasting and fasted state
Secondary study objectives
Plasma hormones, testosterone, SHBG, Estrogen
Plasma insulin and glucose

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: MetforminExperimental Treatment1 Intervention
Metformin tablets (500 mg) 2/day 12 weeks
Group II: Fish Oil and MetforminExperimental Treatment1 Intervention
Combo of other 2 arms
Group III: Fish OilExperimental Treatment1 Intervention
Fish oil capsules 1200mg 6 tablets/day 12 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Metformin
2006
Completed Phase 4
~2430
Fish Oil
2006
Completed Phase 4
~1320

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
939 Previous Clinical Trials
433,733 Total Patients Enrolled
1 Trials studying Polycystic Ovary Syndrome
146 Patients Enrolled for Polycystic Ovary Syndrome
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,388 Previous Clinical Trials
26,517,893 Total Patients Enrolled
2 Trials studying Polycystic Ovary Syndrome
182 Patients Enrolled for Polycystic Ovary Syndrome
Alberta Diabetes InstituteOTHER
3 Previous Clinical Trials
61 Total Patients Enrolled
~2 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top